Publication | Closed Access

The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control

Insulin ResistanceMetabolic SyndromeHypertensionDiabetes ManagementCardiovascular DiseaseHypertensive PatientsMedicineInsulin ManagementDiabetesPhysiologyType 2Antihypertensive TherapyPharmacologyHealth Sciences